What are the latest funding news in the digital health market? (June 2026)
Download our beautiful pitch about the digital health market
In our digital health market deck, you will find everything you need to understand the market
Digital health funding in June 2026 showed strong investor appetite for workflow software, virtual specialty care, clinical AI, and patient-facing health platforms.
The largest recent rounds went to companies helping providers, payers, and care teams reduce administrative burden, improve access, or make clinical data easier to use.
Even when companies served different customer groups, most funding rounds pointed to the same theme: digital health buyers want measurable efficiency, stronger care coordination, and clearer clinical value.
And if you want to better understand this new industry, you can download our pitch covering the digital health market.
Insights
- The 12 latest digital health funding deals represented about $281M, with health IT, clinical workflow software, and provider automation accounting for the largest share of disclosed capital.
- Provider-facing digital health remained especially strong, with Semble, Lassie, Anomaly Insights, Triomics, Subtle Medical, and H1 all selling into clinical or operational healthcare workflows.
- AI was not a standalone theme in most rounds; it was embedded into care delivery, payer intelligence, imaging workflows, provider directories, and administrative automation.
- Virtual specialty care kept attracting capital, especially around cardiometabolic care, obesity care, musculoskeletal care, and chronic disease management.
- The UK showed strong momentum in clinically integrated digital health, with Semble, Flok Health, and Gnosis Health all tied to provider or NHS-facing workflows.
- Most valuations stayed undisclosed, which suggests investors were more focused on growth, clinical adoption, and enterprise traction than public valuation signaling.
- The period favored companies with clear workflow ownership, since many funded startups sit close to the daily systems used by clinicians, clinics, payers, or patients.
- Patient data and connected-device models remained active, but investors appeared to prefer platforms with a clear path to clinical use, reimbursement value, or enterprise partnerships.
As this chart shows, and as featured in our digital health market deck, search interest in longevity apps and related topics has been increasing
Summary table of the latest funding deals in the digital health market as of June 2026
We define the digital health market as products and services that use digital technology to deliver, support, or improve health care and health outcomes.
We include telehealth and virtual care, remote monitoring and connected devices, health IT and clinical workflow software, and patient-facing mobile apps when they are health-focused.
We exclude generic enterprise IT, purely consumer fitness or wellness products with no health use case, and biotech or lab R&D tools unless they directly power care delivery or clinical decision-making.
You can also read our detailed analysis to understand how funding activity in the digital health market has evolved over the last few years.
We also have a quarter-by-quarter analysis of funding activity in the market here.
Finally, you can check our complete list of fundraising deals for the digital health market (we update this list every quarter) as well as our ranking of the most funded startups.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| Semble | 4 June 2026 | ~$40.4M | Series C | Health IT & clinical workflow software |
| Flok Health | 3 June 2026 | ~$12.5M | Series A | Virtual care & AI digital clinic |
| Lassie | 3 June 2026 | $35.0M | Series A | Provider workflow automation & health IT |
| Subtle Medical | 2 June 2026 | $33.0M | Series C / growth | Clinical AI & medical imaging workflow software |
| Novellia | 2 June 2026 | $18.0M | Series A | Patient health records & real-world clinical data platform |
| Ilant Health | 2 June 2026 | $15.0M | Series A | Virtual specialty care & chronic care management |
| Gnosis Health | 2 June 2026 | ~$1.5M | Seed + grant-backed funding | Remote monitoring & chronic disease digital assistant |
| H1 | 28 May 2026 | $40.0M | Strategic investment round | Health data infrastructure & provider workflow software |
| Signos | 27 May 2026 | $20.0M | Unlabeled funding round | Connected devices & patient-facing mobile health |
| Triomics | 27 May 2026 | $22.0M | Series B | Clinical AI & oncology workflow software |
| 9amHealth | 13 May 2026 | $26.0M | Series B | Telehealth & virtual specialty care |
| Anomaly Insights | 13 May 2026 | $17.0M | Additional funding | Health IT & revenue cycle intelligence |
All the latest funding deals during in the digital health market as of June 2026
Semble raised about $40.4M in June 2026 to expand its connected healthcare platform.
When was it?
The Series C deal was announced on 4 June 2026.
Who are they?
Semble is a healthcare operating platform that combines EHR, patient management, payments, scheduling, and AI-enabled workflows for private outpatient providers.
Geographical focus?
Semble is focused on the UK and Europe, with expansion planned across European private healthcare markets.
Why do we include them in the digital health market?
Semble belongs in the digital health market because the platform gives clinics and clinicians the workflow software used to deliver and coordinate care.
What is the company stage?
Semble is at growth stage, with more than 1,700 healthcare businesses, 16,000 professionals, and over 10M patients connected to the platform.
How much did they raise?
Semble raised £30M, which is approximately $40.4M using the GBP/USD conversion provided.
What round is it?
The funding was a Series C round.
Why did they raise?
Semble raised to expand its connected healthcare platform across the UK and Europe and build out its AI orchestration layer for healthcare operations.
Flok Health raised about $12.5M in June 2026 to scale AI physiotherapy.
When was it?
The Series A deal was announced on 3 June 2026.
Who are they?
Flok Health runs an AI-operated physiotherapy clinic that can assess, triage, treat, and discharge musculoskeletal patients digitally.
Geographical focus?
Flok Health is focused first on the UK and NHS pathways, with plans to expand into new clinical pathways and geographies.
Why do we include them in the digital health market?
Flok Health belongs in the digital health market because the company directly delivers digital clinical care through an AI-enabled virtual clinic model.
What is the company stage?
Flok Health is at growth and product-market-fit stage, with NHS-integrated pathways already supporting large patient populations.
How much did they raise?
Flok Health raised £9.5M, reported as about $12.5M.
What round is it?
The funding was a Series A round.
Why did they raise?
Flok Health raised to roll out its NHS-integrated back-pain service more widely and expand into additional clinical pathways and markets.
This chart, featured in our digital health market deck, compares the main business model options for digital health SaaS platforms
Lassie raised $35M in June 2026 to build AI agents for practice operations.
When was it?
The Series A deal was announced on 3 June 2026.
Who are they?
Lassie builds AI agents that automate reimbursements, portals, reconciliation, and system-of-record updates for doctors’ offices and small healthcare practices.
Geographical focus?
Lassie is focused first on U.S. practices, with customers across 49 states.
Why do we include them in the digital health market?
Lassie belongs in the digital health market because the company automates healthcare practice workflows that directly support clinical and administrative operations.
What is the company stage?
Lassie is at early scale, with more than 700 practices supported and more than 250,000 practice hours saved annually.
How much did they raise?
Lassie raised $35M.
What round is it?
The funding was a Series A round.
Why did they raise?
Lassie raised to accelerate adoption of autonomous AI agents that remove repetitive administrative work from practice owners and staff.
Subtle Medical raised $33M in June 2026 to scale AI imaging software.
When was it?
The growth capital round was announced on 2 June 2026.
Who are they?
Subtle Medical makes AI-powered medical imaging software that improves image quality, scan speed, and patient experience across imaging workflows.
Geographical focus?
Subtle Medical is based in Menlo Park and serves the global medical imaging market.
Why do we include them in the digital health market?
Subtle Medical belongs in the digital health market because its clinical AI software supports diagnostic imaging workflows used by healthcare providers.
What is the company stage?
Subtle Medical is at growth stage, with its software reportedly deployed on more than 1,300 scanners globally.
How much did they raise?
Subtle Medical raised $33M.
What round is it?
The financing was growth capital anchored by a Series C round.
Why did they raise?
Subtle Medical raised to scale commercialization of its AI imaging software and accelerate product expansion under new leadership.
This chart, featured in our digital health market deck, shows how Hinge Health captured share in digital health
Novellia raised $18M in June 2026 for patient-powered health data.
When was it?
The Series A deal was announced on 2 June 2026.
Who are they?
Novellia helps patients gather fragmented medical records into one record and consent to share de-identified data for research and evidence generation.
Geographical focus?
Novellia is focused first on the U.S., with pharma and diagnostics customers.
Why do we include them in the digital health market?
Novellia belongs in the digital health market because the platform is built around patient-controlled medical data, patient records, and real-world clinical evidence.
What is the company stage?
Novellia is at early growth stage, with several seven-figure contracts and a newly launched patient-facing app.
How much did they raise?
Novellia raised $18M.
What round is it?
The funding was a Series A round.
Why did they raise?
Novellia raised to scale its patient-powered data platform, strengthen AI technology, and broaden access to consented longitudinal health records.
Ilant Health raised $15M in June 2026 for value-based obesity care.
When was it?
The Series A deal was announced on 2 June 2026.
Who are they?
Ilant Health delivers AI-supported, value-based obesity and cardiometabolic care for employers and health plans.
Geographical focus?
Ilant Health is focused on U.S. employers, payers, and health-plan customers.
Why do we include them in the digital health market?
Ilant Health belongs in the digital health market because the company delivers tech-enabled clinical care and care management for chronic metabolic conditions.
What is the company stage?
Ilant Health is at early growth stage, with employer and health-plan partnerships and more than $22M in total funding.
How much did they raise?
Ilant Health raised $15M.
What round is it?
The funding was a Series A round.
Why did they raise?
Ilant Health raised to expand its value-based obesity care model as employers and health plans manage rising GLP-1 and cardiometabolic-care costs.
In our digital health market deck, we identify pain points entrepreneurs should prioritize
Gnosis Health raised about $1.5M in June 2026 for Parkinson’s care.
When was it?
The seed and grant-backed funding was announced on 2 June 2026.
Who are they?
Gnosis Health is building MAXine, an AI-powered digital healthcare assistant for people with Parkinson’s disease and their care teams.
Geographical focus?
Gnosis Health is focused first on the UK, with NHS pilots as the initial route to clinical adoption.
Why do we include them in the digital health market?
Gnosis Health belongs in the digital health market because the product combines wearables, patient-reported outcomes, and AI insights for chronic disease care support.
What is the company stage?
Gnosis Health is at MVP and pilot stage, with MAXine still linked to enrolled study access and broader availability planned from summer 2026.
How much did they raise?
Gnosis Health raised £1.1M, which is approximately $1.5M using the GBP/USD conversion provided.
What round is it?
The funding was seed investment plus grant-backed funding.
Why did they raise?
Gnosis Health raised to support NHS pilots, grow the engineering team, and prepare MAXine for commercial launch.
H1 raised $40M in May 2026 for healthcare data infrastructure.
When was it?
The strategic investment round was announced on 28 May 2026.
Who are they?
H1 provides AI-powered healthcare data infrastructure, including provider profiles, provider directories, care-navigation data, and workflow intelligence.
Geographical focus?
H1 is U.S.-heavy but serves healthcare, life sciences, payer, provider, and digital health customers globally.
Why do we include them in the digital health market?
H1 belongs in the digital health market because its provider data and AI workflow infrastructure supports patient access, care navigation, and healthcare operations.
What is the company stage?
H1 is at growth and profitable stage, with major payer and pharma customers.
How much did they raise?
H1 raised $40M.
What round is it?
The funding was an unlabeled strategic investment round.
Why did they raise?
H1 raised to expand AI-powered provider data and network intelligence, including provider-directory and patient-access initiatives with CVS.
This market map, featured in our digital health market deck, highlights top companies and startups in the digital health market
Signos raised $20M in May 2026 for glucose-informed weight management.
When was it?
The funding round was announced on 27 May 2026.
Who are they?
Signos offers an FDA-cleared glucose-monitoring system and mobile app that uses CGM data and AI for weight and metabolic health.
Geographical focus?
Signos is focused on the U.S. consumer and metabolic health market.
Why do we include them in the digital health market?
Signos belongs in the digital health market because the company combines connected devices, health data, and a patient-facing mobile app for metabolic health.
What is the company stage?
Signos is at growth stage, with FDA clearance for weight management and an expanded Dexcom Stelo distribution partnership.
How much did they raise?
Signos raised $20M.
What round is it?
The funding was an unlabeled funding round, described as preferred stock financing.
Why did they raise?
Signos raised to accelerate growth of its glucose-informed weight-management system and expand distribution through Dexcom’s Stelo channel.
Triomics raised $22M in May 2026 to expand oncology AI workflows.
When was it?
The Series B deal was announced on 27 May 2026.
Who are they?
Triomics uses AI agents to read oncology records and convert unstructured cancer-care information into workflow outputs for clinicians and researchers.
Geographical focus?
Triomics is focused on U.S. cancer centers, oncology networks, and community oncology groups.
Why do we include them in the digital health market?
Triomics belongs in the digital health market because the platform supports oncology chart review, trial matching, and data abstraction inside clinical workflows.
What is the company stage?
Triomics is at growth and product-market-fit stage, with adoption across leading cancer centers and large community oncology groups.
How much did they raise?
Triomics raised $22M.
What round is it?
The funding was a Series B round.
Why did they raise?
Triomics raised to accelerate adoption across cancer centers, grow its AI and engineering teams, and build more agents for cancer care and research workflows.
This chart, featured in our digital health market deck, shows annual funding in digital health startups
9amHealth raised $26M in May 2026 to expand virtual specialty care.
When was it?
The Series B deal was announced on 13 May 2026.
Who are they?
9amHealth provides virtual specialty care for cardiometabolic conditions such as obesity, diabetes, hypertension, and hyperlipidemia.
Geographical focus?
9amHealth is focused on U.S. employers, health plans, pharmacy benefit managers, and consumers.
Why do we include them in the digital health market?
9amHealth belongs in the digital health market because the company directly delivers virtual chronic-care services through a digital care platform.
What is the company stage?
9amHealth is at growth stage, with enterprise partnerships and reported medical and pharmacy savings across large employers.
How much did they raise?
9amHealth raised $26M.
What round is it?
The funding was a Series B round.
Why did they raise?
9amHealth raised to expand beyond cardiometabolic care into broader high-cost specialty chronic conditions.
Anomaly Insights raised $17M in May 2026 for payer intelligence software.
When was it?
The additional funding round was announced on 13 May 2026.
Who are they?
Anomaly Insights uses AI to analyze payer behavior, denials, claims patterns, and contract issues so providers can recover revenue.
Geographical focus?
Anomaly Insights is focused on U.S. healthcare providers and health systems.
Why do we include them in the digital health market?
Anomaly Insights belongs in the digital health market because the product is healthcare-specific revenue-cycle and payer-intelligence workflow software.
What is the company stage?
Anomaly Insights is at growth and product-market-fit stage, with billions of healthcare transactions analyzed and tens of millions in provider revenue recovered.
How much did they raise?
Anomaly Insights raised $17M.
What round is it?
The funding was an additional funding round, similar to a seed-extension-style financing.
Why did they raise?
Anomaly Insights raised to expand from revenue-cycle intelligence into managed-care and payer-contracting workflows for providers.
Related blog posts
- How strong is fundraising in the digital health market right now?
- The most recent news in digital health
- How big is the digital health market in reality?
- The evolution of funding activity in digital health
- The main fundraising trends in digital health
- All funding deals in digital health
- Which startups have raised the most funding in digital health?
